| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
1991-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2cde422c1eac37f2033b022e9f30fc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5383354a60c6489d87c83bbcfc57bd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0398c77b833dfafd3d3fd2f2ff3e1aeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee343a66a98e3463baca4aa6795a546d |
| publicationDate |
1992-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9203476-A1 |
| titleOfInvention |
Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| abstract |
A biologically active cyclic synthetic peptide analog having an amino acid sequence similar to that of native epidermal growth factor between amino acids 32-48 is revealed. The peptide has been found to mimic certain biological activities of intact native epidermal growth factor (EGF). The EGF peptide analogs of the present invention include at least one sulfhydryl bond between two cysteines of the peptide containing block termini. The peptides comprise the end of the B-loop and the C-loop characteristic of the native form of the epidermal growth factor peptide. The biological activity of the peptide provides for methods of using the peptide as an agent in wound healing and also in cancer therapy. More particularly, the described peptides are used in cancer therapeutic applications and in the promotion of wound healing, especially burn wounds and peptic ulcer disease. Methods of preparing and using the described bioactive EGF analog peptides are also disclosed. Both the D- and L- forms of the peptides' amino acids are within the scope of the described biologically active peptides. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2635293-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9525166-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8207118-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11254716-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015063613-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2635293-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8410055-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6045797-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018067455-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3721896-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012060832-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8455443-B2 |
| priorityDate |
1990-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |